A polylactic acid/hydroxyapatite/scholzite composite scaffold for promoting healing of osteoporotic bone defects in rats

CONCLUSION: PHZ scaffold is capable of stable Zn2+ release to promote osteoporotic bone defect healing, and PHZ-2 and PHZ-3 scaffolds with nZCP mass fraction of 4.5%-7.5% have better osteogenic activity.PMID:38501423 | PMC:PMC10954527 | DOI:10.12122/j.issn.1673-4254.2024.02.20
Source: Journal of Southern Medical University - Category: Universities & Medical Training Authors: Source Type: research